Britta Fuenfstueck appointed as a new member of Clariant’s executive committee, effective April 2016. (File photo)
MUTTENZ, SWITZERLAND: Clariant AG said that it has appointment Britta Fuenfstueck (43) as a new member of its executive committee, effective April 2016.
As of April 2016, the executive committee will consist of CEO Hariolf Kottmann, CFO Patrick Jany, Britta Fuenfstueck and Christian Kohlpaintner.
Britta Fuenfstueck (43) has been CEO of the clinical products division at Siemens Healthcare since 2013. During her career with Siemens, she held various leadership positions, including CEO of the Molecular Imaging Business Unit, Vice President, Strategy and M&A for the Healthcare Sector, as well as Director, Product Portfolio and Planning, Marketing and Sales, for Siemens' Magnetic Resonance Business Unit. Fuenfstueck began her career with the Boston Consulting Group in 1998.
“With her extensive international experience as a senior executive in the technology industry, Britta Fuenfstueck will be a strong addition to our management team and will bring valuable insights and perspectives,” said Hariolf Kottmann, CEO, Clariant.
© Worldofchemicals News